Lexicon Pharmaceuticals Selects Medidata to Aid in Advancing Phase IIb Trial of Non-Opioid Drug for Neuropathic Pain
![BrainSightAI Collaborate with Medidata and Dassault Systèmes](https://www.medidata.com/wp-content/uploads/2022/05/brainsightai-collaborate-with-medidata-and-dassault-systemes-768x432.jpg)
Lexicon will use Medidata’s decentralized clinical trial solutions to help advance in the Phase IIb LX9211 study to develop new treatments for diabetic peripheral neuropathy.